|
Volumn 15, Issue 4, 2006, Pages 322-
|
Bisphosphonate therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
BONE NECROSIS;
CHEMICALLY INDUCED DISORDER;
DRUG CONTRAINDICATION;
HUMAN;
INFORMED CONSENT;
NOTE;
PATIENT CARE PLANNING;
RISK ASSESSMENT;
TOOTH IMPLANTATION;
BONE DENSITY CONSERVATION AGENTS;
DENTAL IMPLANTATION, ENDOSSEOUS;
DIPHOSPHONATES;
HUMANS;
INFORMED CONSENT;
OSTEONECROSIS;
PATIENT CARE PLANNING;
RISK ASSESSMENT;
|
EID: 33845761853
PISSN: 10566163
EISSN: None
Source Type: Journal
DOI: 10.1097/ID.0b013e31802ef7ee Document Type: Note |
Times cited : (4)
|
References (0)
|